The population of Pharmaceutical Product Development is 2,012.
Pharmaceutical Product Development's population is 11,500.
Pharmaceutical Product Development was created in 1985.
The population of Synapse Product Development is 101.
The population of BioMarin Pharmaceutical is 700.
The population of Mochida Pharmaceutical is 2,006.
Sun Pharmaceutical's population is 2,012.
Par Pharmaceutical's population is 775.
The population of Par Pharmaceutical is 2,005.
Nanjing Ange Pharmaceutical's population is 2,007.
The population of Rohto Pharmaceutical Co. is 4,878.
The BSN Cell Mass is a type of pharmaceutical product that promotes the development of muscle mass and shortens the recovery duration after exercise. The product sells for $40.00 for 30 capsules.
Fisons, a British pharmaceutical and agricultural company, was acquired by the pharmaceutical giant Zeneca Group PLC in 1996. The acquisition was part of Zeneca's strategy to expand its product offerings and strengthen its market position. Fisons' integration into Zeneca allowed for enhanced research and development capabilities in the pharmaceutical sector.